We are live on ! Find out more
ENSC icon

Ensysce Biosciences
ENSC

8 hedge funds and large institutions have $103K invested in Ensysce Biosciences in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.01% less ownership

Funds ownership: 0.03% → 0.02% (-0.01%)

25% less capital invested

Capital invested by funds: $138K → $103K (-$35.1K)

38% less funds holding

Funds holding: 13 → 8 (-5)

63% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 8

Holders
8
Holders Change
-5
Holders Change %
-38.46%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
–
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$103K
2
PIA
Powell Investment Advisors
Florida
+$25.5K
3
UBS Group
UBS Group
Switzerland
+$10.7K
4
TRCT
Tower Research Capital (TRC)
New York
+$4.59K
5
ASN
Advisory Services Network
Georgia
+$2.64K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$31.7K
2
Two Sigma Investments
Two Sigma Investments
New York
-$29.9K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$19K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$13.2K
5
Millennium Management
Millennium Management
New York
-$11K
Name Holding Trade Value Shares
Change 		Change in
Stake
VF
1
Virtu Financial
New York
$65K +$103K +896 New
PIA
2
Powell Investment Advisors
Florida
$16.2K +$25.5K +222 New
UBS Group
3
UBS Group
Switzerland
$12.4K +$10.7K +93 +121%
BlackRock
4
BlackRock
New York
$4.74K – – –
TRCT
5
Tower Research Capital (TRC)
New York
$3K +$4.59K +40 +1,000%
ASN
6
Advisory Services Network
Georgia
$1.69K +$2.64K +23 New
PMFA
7
Plante Moran Financial Advisors
Michigan
$97 – – –
WAM
8
Wolverine Asset Management
Illinois
$58 – – –
Wells Fargo
9
Wells Fargo
California
$24 – – –
Citadel Advisors
10
Citadel Advisors
Florida
– -$31.7K -235 Closed
Two Sigma Investments
11
Two Sigma Investments
New York
– -$29.9K -222 Closed
Acadian Asset Management
12
Acadian Asset Management
Massachusetts
– -$19K -148 Closed
Susquehanna International Group
13
Susquehanna International Group
Pennsylvania
– -$13.2K -98 Closed
Millennium Management
14
Millennium Management
New York
– -$11K -80 Closed
Stifel Financial
15
Stifel Financial
Missouri
– -$8.12K -60 Closed
Bank of America
16
Bank of America
North Carolina
– -$4.54K -34 Closed
Morgan Stanley
17
Morgan Stanley
New York
– -$207 -2 Closed

ENSC Hedge Fund Activity: Q1 2023 in Review

8 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Ensysce Biosciences (ENSC) for Q1 2023, worth a combined $103K — down 25% from $138K a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of ENSC and 3 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 2 added.

The largest buyer was Virtu Financial, opening a new position worth an estimated $103K. The largest seller was Citadel Advisors, exiting entirely with an estimated $31.7K sold.

  • 8 institutional investors held Ensysce Biosciences (ENSC) as of Q1 2023, down from 13 in Q4 2022.
  • Funds reported $103K of Ensysce Biosciences stock for Q1 2023, down 25% quarter-over-quarter.
  • 3 funds opened new Ensysce Biosciences positions in Q1 2023 and 8 closed out, a net change of -5 holders.
  • The largest Ensysce Biosciences buyer in Q1 2023 was Virtu Financial, an estimated $103K added.
  • The largest Ensysce Biosciences seller in Q1 2023 was Citadel Advisors, an estimated $31.7K sold.

Based on aggregated 13F filings for Q1 2023.